{"id":"NCT01617460","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder","officialTitle":"A Long-term Administration Study of Aripiprazole in Children and Adolescents (Age: 6 to 17 Years) With Autistic Disorder","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-09","primaryCompletion":"2016-10","completion":"2016-10","firstPosted":"2012-06-12","resultsPosted":"2017-10-20","lastUpdate":"2024-08-06"},"enrollment":86,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Autistic Disorder"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":[]}],"arms":[{"label":"Aripiprazole","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to investigate the safety and efficacy of aripiprazole orally administered over long term in subjects who complete a short-term treatment study of pediatric Autistic Disorder (031-11-002 study).","primaryOutcome":{"measure":"Mean Change From Baseline at the Final Assessment in Aberrant Behavior Checklist Japanese Version (ABC-J) Irritability Subscale Score","timeFrame":"Baseline, the final administration","effectByArm":[{"arm":"Aripiprazole","deltaMin":-3.2,"sd":8.1}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":["28941259"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":86},"commonTop":["Nasopharyngitis","Somnolence","Influenza","Weight increased","Vomiting"]}}